DNALite
An early-stage preclinical biotechnology company that is making DNA based gene-therapy drugs for the gastrointestinal (GI) tract by leveraging new drug delivery technologies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€32—49m (Dealroom.co estimates May 2022.)
San Francisco California (HQ)
Authorizing premium user...